GLP-1 receptor agonists are a class of injectable medications that mimic the action of a naturally occurring hormone secreted by the small intestine in response to food entering the small intestine
However, patients may experience minor side effects, such as injection site reactions (redness, swelling, or itching) or gastrointestinal symptoms (nausea, vomiting, or diarrhea)
Pros and Cons Pros Accelerates healing across multiple tissue types Non-hormonal (doesnt disrupt the endocrine system) Targets both acute injuries and chronic conditions Can be used locally or systemically Generally well-tolerated with minimal side effects Works synergistically with TB-500 for enhanced healing Cons Limited large-scale human clinical trials Regulatory status varies by country The injectable form requires a proper administration technique Quality can vary between suppliers Optimal dosing protocols are still being established Who Should Use BPC-157
In contrast, the rectal temperature in the BCTC-treated group rapidly increased by 0.71.5 C and returned to baseline values at 12 min postadministration (Fig
Results Among the 26,944 adults with T2D, 7392 individuals were selected following PSM, with 1848 patients in each group
It is therefore challenging to separate the homodimer and hybrid receptor activation properties